Home
About
Overview
Sharing Data
ORCID
Help
History (18)
CLO26-104: TBCRC 050: A Phase 1b/2 Trial of Niraparib and Trastuzumab in HER2+ Metastatic Breast Cancer (MBC): Safety and Efficacy.
Peripheral blood gene expression signatures of systemic immunity predict tumor microenvironment biology and therapeutic response in breast cancer.
Breast cancer recurrence and mortality among survivors of childhood cancer.
Racialized inequities in live birth after cancer: A population-based study of 63,000 female adolescents and young adults with cancer.
Colorectal Cancer Screening Receipt Does Not Differ by 10-Year Mortality Risk Among Older Adults.
See All 18 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Colorectal Cancer Screening Receipt Does Not Differ by 10-Year Mortality Risk Among Older Adults.
Colorectal Cancer Screening Receipt Does Not Differ by 10-Year Mortality Risk Among Older Adults. Am J Gastroenterol. 2024 02 01; 119(2):353-363.
View in:
PubMed
subject areas
Aged
Colorectal Neoplasms
Early Detection of Cancer
Humans
Life Expectancy
Mass Screening
Prevalence
Surveys and Questionnaires
authors with profiles
Caitlin Murphy